World Orphan Drug Congress Europe 2026

We treat your trial like it’s the only trial that matters. Because for your patients, it is.

World Orphan Drug Congress Europe 2026 | October 27-28, 2026 | Amsterdam, The Netherlands

At World Orphan Drug Congress Europe 2026, meet the Ergomed Clinical Research team to discuss how we help sponsors reduce uncertainty and strengthen execution across rare disease clinical development. From early study strategy and feasibility to patient engagement, site support, and global trial delivery, Ergomed brings the cross-functional expertise needed to turn high-stakes rare disease study plans into trials that move forward with greater confidence.

Request a meeting

Speaking Session

“Driven by Insights: Operationalizing Patient-Centric Design in Rare Disease Programs”

Day 1 | 15:10

Paula Orandash
Director, Patient Engagement, Strategic Solutions and Patient Centricity
Jennifer Verde
Associate Director, Clinical Data Operations at Rezolute

In this session, Paula and Jennifer will share how biotech companies and CROs can move patient-centric study design from concept to execution. Drawing on real-world experience in rare disease trials, they will explore practical strategies for keeping patient needs at the core of trial design, thereby improving both the patient experience and overall study outcomes.

Meet our Experts

Connect with us at Booth #302 for conversations with biotech and pharmaceutical teams looking for a specialty CRO partner built for complex rare disease studies, vulnerable populations, and high-pressure development decisions.

Marija Flego
Senior Director, Project Management
Benjamen Varsano
Director, Operational Strategy, Strategic Solutions and Patient Centricity
Yanis Merabet
Director, Business Development

Built for the realities of rare disease development.

Rare disease development demands more than operational scale. It demands a CRO partner that can simplify complexity without losing sight of the patients, families, sites, and care networks at the center of every study.

Ergomed Clinical Research supports sponsors navigating:

  • small and geographically dispersed patient populations
  • limited natural history data
  • endpoint uncertainty
  • complex regulatory and evidence-generation pathways
  • caregiver and family burden
  • referral pathway challenges
  • site readiness and retention risk
  • complex logistics across countries, patients, and sites

We work as an extension of your team to help bring greater clarity, stronger coordination, and disciplined delivery to every stage of rare disease clinical development.

Let’s discuss your rare disease development needs!

If you are planning a rare disease study and looking for a CRO partner that understands how to combine strategic insight, patient-centered thinking, and rigorous execution, we would welcome the conversation. Meet Ergomed Clinical Research at Booth #302 during World Orphan Drug Congress Europe 2026 to discuss how we help sponsors make complex rare disease development more executable — from early planning through clinical delivery.

Setup a Meeting

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
By submitting this form, you consent to your personal data submitted in the form being processed in alignment with our Online Privacy and Cookies policy. Your personal data will be processed to facilitate your request and may be used for sending you additional marketing and business development-related information about Ergomed, its affiliates, and our services. You can withdraw your consent anytime by messaging marketing@ergomedgroup.com, and we will promptly remove your data from our records. For more information about how we will process your personal data and your rights, please see our Online Privacy and Cookies policy.